 |
|
Etretinate Therapy Causes Increases in Lipid Levels in Patients With Psoriasis
Charles N. Ellis, MD;
Neil A. Swanson, MD;
Roy C. Grekin, MD;
Nancy G. Goldstein, MPH;
David R. Bassett, MD;
Thomas F. Anderson, MD;
John J. Voorhees, MD
Arch Dermatol. 1982;118(8):559-562.
Abstract
 We investigated changes in serum triglyceride, cholesterol, and high-density lipoprotein cholesterol (HDLC) levels during etretinate administration in 21 patients with psoriasis. Mean serum triglyceride and cholesterol values showed a statistically significant increase during etretinate therapy compared with placebo treatment; mean HDLC levels did not change. During etretinate therapy, elevations out of the normal range occurred in 77% of the patients for serum triglycerides and in 25% for serum cholesterol. Eight weeks after discontinuation of the drug regimen, patients' mean serum triglyceride and cholesterol levels were not statistically different from those found prior to therapy. Nevertheless, eight weeks after therapy had been stopped, six (32%) of 19 patients had cholesterol values that were still 20% or more above their baseline levels; the prolonged etretinate excretion time could have been responsible. The mechanisms for the etretinate-induced lipid elevations are unknown.
(Arch Dermatol 1982;118:559-562)
Author Affiliations
From the Department of Dermatology (Drs Ellis, Swanson, Grekin, Anderson, and Voorhees and Ms Goldstein) and the Division of Hypertension, Department of Internal Medicine (Dr Bassett), University of Michigan Medical School, and the Dermatology Service, Veterans Administration Medical Center (Drs Ellis and Anderson), Ann Arbor, Mich.
Footnotes
Accepted for publication Dec 23, 1981.
Reprint requests to Dermatology Service (110), Veterans Administration Medical Center, 2215 Fuller Rd, Ann Arbor, MI 48105 (Dr Ellis).
 CiteULike  Connotea  Delicious  Digg  Facebook  Reddit  Technorati  Twitter
What's this?
THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES
Retinoic acid represses CYP7A1 expression in human hepatocytes and HepG2 cells by FXR/RXR-dependent and independent mechanisms
Cai et al.
J. Lipid Res. 2010;51:2265-2274.
ABSTRACT
| FULL TEXT
How Can Hand Searching the Dermatological Literature Benefit People With Skin Problems?
Delamere and Williams
Arch Dermatol 2001;137:332-335.
FULL TEXT
Glucose and Insulin Responses Are Improved in Patients With Psoriasis During Therapy With Etretinate
Ellis et al.
Arch Dermatol 1987;123:471-475.
ABSTRACT
Etretin Therapy for Severe Psoriasis: Evaluation of Initial Clinical Responses
Kingston et al.
Arch Dermatol 1987;123:55-58.
ABSTRACT
|
